These trials completed more than 12 months ago and should have reported results. Some have, some have not.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Not reported Terminated||2007-002547-25||A Phase 2 Study of an Aptameric von Willebrand Factor Antagonist, ARC1779, in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention||2008-03-18||due-trials|
|Not reported||2007-004371-19||A Phase 2 Pilot Study of the Safety, Pharmacokinetics, and Pharmacodynamics of ARC1779 Injection in Patients with von Willebrand Factor-Related Platelet Function Disorders||2008-12-09||due-trials|
|Not reported Terminated||2008-001872-54||A Randomized, Double-blind, Placebo-controlled, Clinical Outcome study of ARC1779 Injection in Patients with Thrombotic Microangiopathy||2009-11-13||due-trials|
|Not reported Terminated||2008-005246-23||A Study of the Effect of ARC1779 Injection on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy||2010-01-27||due-trials|